Retension Pharmaceuticals, Inc. — Form 4
Filed October 13, 2026 · analyzed by the Insider Agent
4
▲ Likely positive
significance 52/100
What the filing says
CHIEF EXECUTIVE OFFICER Keller Eric L. (RTSN) bought 317K shares (~$250K) on the open market (55% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating
Open-market insider purchase — historically a bullish signal.
See more from October 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.